ESR1 and breast carcinoma: Since estrogen-resistant breast cancers pose a major risk to breast cancer patients, we asked whether EGCG may facilitate the epigenetic processes leading to ERα re-expression in ERα-negative breast cancer cells and whether combination epigenetic approaches may have synergistic effects in these cells.